ALKERMES | Custo De Mercadoria Vendida



Cost Of Sales Alterar Data
AbbVie USD 4.4B 184M 2024-12
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
ALKERMES USD 62.12M 984K 2024-12
Amgen USD 3.11B 198M 2024-12
Biogen USD 583.5M 55.2M 2024-12
BioMarin Pharmaceutical USD 136.14M 52.32M 2024-12
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Eli Lilly USD 2.4B 233M 2024-12
Gilead Sciences USD 1.58B 7M 2024-12
Intra Cellular Therapies USD 20.4M 5.1M 2024-12
Ionis Pharmaceuticals USD 3.83M 2.76M 2024-12
J&J USD 7.11B 151M 2024-12
Malin Corporation EUR 15.4M 0 2020-12
Merck USD 3.71B 181M 2024-12
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
Otsuka Holdings JPY 177.69B 11.16B 2024-12
Pfizer USD 5.65B 781M 2024-12
Regeneron Pharmaceuticals USD 565.4M 74.3M 2024-12
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



ALKERMES Custo De Mercadoria Vendida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.